Feedback / Questions
IMP761 - Immutep
https://www.globenewswire.com/news-release/2025/06/23/3103327/0/en/Immutep-Announces-Positive-Update-from-Phase-I-Study-of-IMP761-a-First-in-Class-LAG-3-Agonist-Antibody-for-Autoimmune-Diseases.html
Jun 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next